AusPAR: Evolocumab (rch)
Australian Public Assessment Report
Device/Product Name
Repatha
Active ingredients
Evolocumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2014-03144-1-3
Submission Type
New biological entity
Decision
Approved